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Purpose: Long-term outcomes in patients undergoing emergency versus elective resection for 
colorectal cancer (CRC) are discussed controversially. This study aims to assess long-term 
outcomes of emergency versus elective CRC surgery. 
Methods: Single center retrospective cohort study. Patients undergoing emergency or elective 
CRC surgery from July 2002 to January 2013 were included. Primary outcome was 5-year 
survival, secondary outcomes were in-hospital mortality and local tumor recurrence. 
Results: Overall, 475 patients were included. Median age was 69.0 (IQR 59.0-77.0) years. A 
total of 141 patients (30%) were operated for rectal cancer and 334 patients (70%) for colon 
cancer. Median follow-up was 445 (IQR 67-1409) days. Emergency resection was performed in 
105 patients (22%) due to obstruction, perforation or bleeding. Stage IV tumors and ASA 
scores≥3 were significantly more frequent in the emergency than in the elective resection group 
(39.0% vs. 33.5%, p<0.001; 75.5% vs. 61.3%, p=0.003). The rate of patients with positive lymph 
nodes was similar in the two groups (46.2% vs. 46.3%, p=1.000). In-hospital mortality was 
significantly higher in the emergency CRC versus the elective CRC group (8.4% vs. 3.0%, 
p=0.023). Five-year survival (aHR 1.38; 95%CI 0.81-2.37, p=0.237) or local tumor recurrence 
(aHR 1.48; 95%CI 0.47-4.66, p=0.500) were not significantly different in patients undergoing 
emergency versus elective surgery for CRC. 
Conclusion: In-hospital mortality was increased in emergency versus elective CRC resections. 
However, 5-year survival and local recurrence after surgery for CRC were determined by the 
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Colorectal cancer (CRC) is the third most common cancer worldwide [1]. In 2015, CRC had an 
incidence of 1.7 million cases and accounted for 832 000 deaths worldwide [2]. Approximately a 
quarter to a third of CRC patients undergo emergency CRC surgery due to obstruction, 
perforation or bleeding ahead of termination of a neo-adjuvant chemo-/radiotherapy or 
scheduled resection [3,4]. 
As randomization in elective and emergency CRC surgery is not feasible, the literature is 
inherently non-randomized and therefore mainly retrospective. Some studies suggest that 
overall survival and disease-free survival after emergency CRC surgery are worse than after 
elective CRC surgery. However, these studies either have a relatively short follow-up [5,6], small 
sample sizes [7,8] or do not adjust outcomes for confounding factors [9,10,5,7,8]. Therefore, 
further assessment of long-term outcomes after emergency versus elective CRC surgery is 
warranted. 
Inconsistent preoperative diagnostics or cancer-related surgery in the emergency setting might 
be reasons for the suggested worse outcomes in patients undergoing emergency CRC surgery. 
Most commonly, differences in surgical technique between emergency general surgeons and 
highly specialized colorectal surgeons are discussed as contributing factors. Nevertheless, there 
is no consensus in the literature whether emergency CRC surgery negatively influences long-
term, cancer-related outcomes [11-13]. 
Therefore, the aim of this study is to assess long-term outcomes after emergency versus 





Material and Methods 
Study design 
This is a single center retrospective observational study. Patients undergoing CRC surgery at 
the Bern University Hospital from 07/2002 to 01/2013 were included. Patient data was extracted 
from the institution’s CRC database and electronic patient charts. The following variables were 
collected: age, sex, body mass index (BMI), American Society of Anesthesiologists (ASA) 
score[14], Charlson Comorbidity Index (CCI)[15], operative procedure, surgical technique 
(laparoscopic/open) and strategy (primary anastomosis/primary anastomosis with protective, 
diverting stoma/definitive stoma), tumor localization, postoperative histologic Union for 
International Cancer Control (UICC, ed. 2010) tumor stage, overall and positive lymph node 
yield, neo-adjuvant chemo- and radio-therapy, operation time, postoperative complications 
(cardio-pulmonary, renal, gastrointestinal, surgical site infections), hospital length of stay 
(HLOS), in-hospital mortality, length of follow-up, overall survival 5 years survival, rate of local 
recurrence, and disease free survival. In cases with missing variables, patients and/or 
responsible general practitioners were contacted by phone. 
Patients undergoing emergency resection for CRC were compared to patients undergoing 
elective resection for CRC. Patients undergoing stoma formation without CRC resection or other 
palliative surgical techniques were not included into the study. 
Short-term outcomes comprised postoperative complications and in-hospital mortality. Long-
term outcomes were determined for those patients surviving the index hospitalization. A 
subgroup analysis for colon cancer (with the exclusion of patients with rectal cancer) was 





All CRC patients were discussed at the Multidisciplinary Team Meeting and treated based on the 
European Society of Medical Oncology (ESMO) guidelines [16]. This included neo-adjuvant 
chemo-/radiotherapy in advanced lower- and mid-rectal cancer and adjuvant chemotherapy in 
patients with advanced CRC. Oncologic resection included high-tie ligation of the feeding colonic 
vessels in colon cancer or total mesorectal excision [17] in patients with rectal cancer. Surgeons 
specialized in colorectal procedures performed most of the elective CRC resections. Surgeons 
from various abdominal surgical subspecialties such as general surgeons, colorectal, pancreatic, 
hepatobiliary or upper gastrointestinal surgeons performed emergency CRC resections. 
 
Statistical analysis 
The Shapiro-Wilk test was used assessing normality of distribution. Categorical variables were 
reported as numbers and percentages, continuous variables as medians and interquartile 
ranges (IQR). In univariable analysis categorical variables were compared using Fisher’s exact 
test and continuous variables were compared using Mann-Whitney U test. The effect of 
emergency CRC surgery on short- and long-term outcomes was adjusted in multivariable logistic 
and Cox regression analysis, respectively. Clinically relevant predictor variables with p≤0.1 in 
univariable analysis were included in the regression models. P-values ≤0.05 were considered 
statistically significant. 






This study is reported in accordance with the STROBE (Strengthening the Reporting of 
Observational Studies in Epidemiology) statement [18] and was approved by the cantonal ethics 





Baseline demographics and characteristics 
During the 10.5 years study period, a total of 475 patients with CRC resections were included in 
the study. Median age was 69.0 (IQR 59.0-77.0) years, 62.3% were male and the median BMI 
was 25.5 (IQR 22.7-28.9) kg/m2. An ASA score≥3 was found in 61.9% and the CCI≥5 was found 
in 79.4% of patients. Patients were treated for colon cancer in 70.3% and for rectal cancer in 
29.7%, respectively. 
A total of 105 (22.1%) patients underwent emergency CRC resections due to obstruction 
(63.8%), perforation (17.1%) or bleeding (14.3%), respectively. Table 1 summarizes the baseline 
characteristics of the emergency versus elective CRC resection populations. Patients 
undergoing emergency CRC surgery were significantly older and presented with a lower BMI 
compared to the elective CRC surgery patients (72.0 vs. 68.0 years, p=0.018; 24.3 vs. 25.9 
kg/m2, p=0.012). Moreover, in the emergency CRC surgery group ASA scores≥3 were 
significantly more frequent than in the elective CRC surgery group (75.5% vs. 61.3%, p=0.003). 
Median operative time was significantly shorter in the emergency CRC surgery group compared 
to the elective CRC surgery group (265 vs. 280min., p=0.042). The proportion of laparoscopic 
resections was significantly smaller in the emergency CRC surgery group compared to the 
elective CRC group (4.8% vs. 12.4%, p=0.031). Stoma formation was significantly more frequent 
in the emergency CRC group compared to the elective group (59.2% vs. 44.8%, p=0.003) (Table 
1). 
Tumor characteristics 
Table 2 summarizes the tumor characteristics of emergency versus elective CRC patients. T4 
carcinomas were significantly more frequent in the emergency compared to the elective CRC 
group (42.9% vs. 16.5%, p<0.001). Moreover, significantly more lymph nodes were harvested in 
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the emergency CRC surgery group versus the elective CRC surgery group (26 [IQR 18-33] vs. 
20 [15-27] lymph nodes, p<0.001). Colon cancer (as compared to rectal cancer) was 
significantly more frequent in the emergency CRC group (90.5% vs. 64.6%, p<0.001). 
Significantly more patients from the elective CRC group received adjuvant chemotherapy 
compared to the emergency CRC group (32% vs. 19%, p=0.028). 
Short-term outcomes 
Table 3 summarizes in-hospital outcomes of emergency versus elective CRC patients. The 
median HLOS was significantly longer in the emergency CRC surgery group compared to the 
elective CRC surgery group (14 [IQR 11-23] vs. 13 [9-19] days, p=0.006). There was a trend 
towards more in-hospital complications in the emergency versus the elective CRC group. 
However, this difference did not reach statistical significance (67 complications in 62 [59.0%] 
emergency CRC patients vs. 201 complications in 187 [50.5%] elective CRC patients, p=0.150). 
In-hospital mortality was significantly higher in the emergency CRC versus the elective CRC 
group (8.4% vs. 3.0%, p=0.023). However, when adjusting for the effect of ASA score, tumor 
localization, operative strategy, neoadjuvant chemo- and radiotherapy in-hospital mortality was 
not significantly different in the emergency versus the elective CRC group (OR 1.82, CI 95% 
0.62-5.40, p=0. 278) 
 
Long-term outcomes 
Long-term outcomes are summarized in Table 3. Median length of follow-up was 445 (IQR 67-
1409) days and was similar between the emergency and elective CRC groups. Neither overall 
survival nor median disease free survival were significantly different between the emergency and 
the elective CRC groups (72.4% vs. 78.9%, p=0.185; 383 vs. 423 days, p=0.257) (Figure 1). 
Multivariable Cox regression analysis confirmed comparable 5-year survival or local tumor 




Subgroup-analysis of patients with colon cancer 
In order to reduce heterogeneity of the study population, a subgroup-analysis of patients with 
colon cancer (n=334) was performed. The same baseline characteristics as presented in Table 1 
were compared between emergency (28.4%) and elective colon cancer resections (71.6%). As 
in the overall study population, it was found that the emergency colon cancer group was 
significantly older (74.0 vs. 69.0 years, p=0.017), had a significantly lower BMI (24.3 vs. 25.9 
kg/m2, p=0.022) and significantly more often ASA scores≥3 (76.4% vs. 63.0%, p=0,013) 
compared to the elective colon cancer group. Stoma formation was performed in 56.9% of 
emergency colon cancer patients versus 25.5% of elective colon cancer patients (p<0.001). 
Similar to the entire CRC population, T4 carcinomas were significantly more frequent in the 
emergency versus elective colon cancer group (43.2% vs. 21.3%, p=0.017). Moreover, 
significantly more lymph nodes were harvested in the emergency versus elective colon cancer 
group (26 [IQR18-37] vs. 22 [16-30], p=0.017). In the emergency surgery group, left-sided colon 
tumors were significantly more frequent compared to the elective colon cancer group (68.4% vs. 
49.0%, p=0.001). No differences were found regarding in-hospital complications rates. However, 
similar to the entire CRC group, the median HLOS was significantly longer in emergency versus 
elective colon cancer patients (14 [IQR 10-22] vs. 11 [8-17] days, p=0.001). 
In the subgroup of colon cancer patients, the median length of follow-up was 438 (IQR 50-1465) 
days and did not differ significantly between emergency and elective resections. As found for the 
entire CRC group, neither the overall survival nor the median disease free survival were 
significantly different between the emergency and the elective colon cancer resection group 
(72.6% vs. 77.8%, p=0.321; 389 vs. 434 days, p=0.583). Multivariable cox regression analysis 
showed no statistical significant differences in 5-year survival (aHR 1.40; 95%CI 0.78-2.51, 
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p=0.260) or local tumor recurrence (aHR 1.44; 95%CI 0.32-6.56, p=0.635) when comparing 




The current study assessed long-term outcomes of CRC patients undergoing emergency versus 
elective CRC surgery based on an institutional CRC database. Emergency CRC patients 
presented with locally more advanced tumors and less frequent rectal cancer compared to 
elective CRC patients. In-hospital mortality was significantly increased in the emergency versus 
the elective CRC group. However, the long-term oncologic outcomes were similar between the 
groups. Similar results were found for the subgroup of patients with colon cancer. 
 
Tumor characteristics 
In the current study, more advanced tumor stages were observed in the emergency CRC 
compared to the elective CRC group. This finding is not surprising as large tumors are more 
likely to cause obstruction, perforation or bleeding, which were the reasons for emergency 
resections. Moreover, in the current study, patients in the emergency CRC group suffered more 
frequently from colon cancer compared to the elective group (91% vs. 65%). This is due to the 
higher incidence of colon compared to rectal cancer in general and the fact that the study 
institution is a referral center for elective rectal cancer treatment. Therefore, a subgroup analysis 
was performed for patients with colon cancer only to reduce heterogeneity of the populations. 
However, similar to the entire CRC population, this subgroup analysis revealed comparable 
results regarding short- and long-term outcomes between the emergency and elective 
resections. 
The higher frequency of neo-adjuvant radio- and chemotherapy is well explained by the higher 
number of patients with rectal cancer in the elective CRC group. The higher proportion of 
patients with neo-adjuvant therapy may have resulted in a trend towards less local tumor 
recurrence in the elective CRC group compared to the emergency CRC group. However, overall 
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survival was similar between the two groups (Table 3). This is in line with previous investigations 
showing that neo-adjuvant therapy does decrease local tumor recurrence, but not overall 
survival [19,20]. Significantly more patients from the elective CRC group received adjuvant 
chemotherapy compared to the emergency CRC group (32% vs. 19%, p=0.028). This might be 
explained by the higher morbidity and in-hospital mortality in the emergency CRC group 
prohibiting adjuvant chemotherapy. In the subgroup analysis of colon cancer patients no 
statistical significant difference regarding adjuvant chemotherapy between the elective versus 
emergency resection group was found (26% vs. 19%, p=0.283)  
 
Short-term outcomes 
In the current study, 8% in the emergency CRC group and 3% in the elective CRC group died 
during their hospital stay (p=0.023). Cardiopulmonary events were the most common 
complications, and occurred more frequently in the emergency CRC group (Table 3). The 
literature on short-term outcomes after emergency versus elective CRC surgery is conflicting. 
Due to varying methodology and different short-term outcomes measures, the generalizability of 
these studies is limited [6,5]. It is important to consider acute systemic pathophysiologic 
derangements when comparing short-term outcomes of emergency to elective patients. In the 
current study, the ASA scores, as a surrogate marker for acute systemic pathophysiologic 
derangement, were significantly higher in the emergency than in the elective CRC group (Table 
1). To our knowledge, there is currently only one previous study in CRC patients, which similarly 
found the ASA score to be an independent predictor for in-hospital mortality [6]. In addition, 
emergency CRC patients often present with reduced physiologic reserves, including a katabolic 
malnutritional state, due to the advanced malignant disease and no possibility for prehabilitation 
[21]. In the current study, the worse nutritional state is reflected by the significantly lower BMI in 
the emergency CRC group compared to the elective CRC group (24 vs. 26 kg/m2, p=0.012). In 
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order to improve pathophysiology and therefore short-term outcomes in this group of frail 
patients, an interdisciplinary approach, involving emergency physicians, surgeons, 
anesthesiologists, nutritionists, and intensivists is required. 
 
Long-term outcomes 
Oncologic outcomes in CRC patients are associated to multiple disease- and patient-related 
factors. As expected, when stratifying the current study population according to the UICC-
grades, significant differences between the five-year survival rates were observed (Figure 2). 
Moreover, the completeness of surgical resection, characterized by the negative resection 
margins (R0) and the lymph node yield, determines overall survival [22,23]. In the current study, 
the percentage of R0-resections was 92% versus 95% and the median lymph node yield was 26 
versus 20 lymph nodes when comparing emergency with elective CRC patients. Overall, this 
represents a good quality of oncologic resection for both study groups [22,23]. Unexpectedly, the 
number of harvested lymph nodes was significantly higher in emergency than in elective CRC 
resections. This finding accounted for both, colon and rectal resections (Table 2). To our 
knowledge, three recent studies have compared the lymph node yield of emergency with 
elective CRC resections [13,24,4]. However, the results are conflicting. In these three studies the 
percentage of adequate lymph node yield (>12 lymph nodes) is higher [13], equal [24] or lower 
[4] for emergency compared to elective CRC resections. The reasons for these conflicting 
findings remain unclear. Differences in training between general emergency surgeons and 
specialized colorectal surgeons have been discussed, however, only in elective CRC surgery 
[25]. The good oncologic resection quality in the emergency CRC population might be result of 
the common trunk education and the close collaboration of general emergency surgeons with 
specialized colorectal surgeons. 
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A recent retrospective single-institution study from Canada demonstrated a difference in local 
tumor recurrence and five-year survival between elective and emergency resection of colon 
cancer [24]. However, in a selected patient population of stage I to III colon cancer and without 
adjustment for comorbidities in multivariable analysis. Therefore, this finding needs to be 
considered carefully. 
 
Limitations of the current study are its retrospective design and relatively low number of patients. 
 
Conclusion 
In-hospital mortality in patients undergoing emergency CRC surgery was higher compared to 
patients undergoing elective CRC surgery. However, adjusted five-year survival, rate and time to 
local tumor recurrence were similar between the groups. Increased tumor stages and not 
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Figures and Tables 
Table 1: Baseline characteristics 
 Overall (N=475) Emergency (n=105) Elective 
(n=370) 
p value 
Age, y, median (IQR) 69.0 (59.0-77.0) 72.0 (61.5-79.0) 68.0 (58.8-76.0) 0.018a 




BMI, kg/m2, median (IQR) 25.5 (22.7-28.9) 24.3 (21.8-27.4) 25.9 (22.9-29.1) 0.012a 
ASA score, n (%)    0.003b 
 1 7 (1.5) 1 (1.0) 6 (1.7)  
 2 156 (32.8) 23 (23.5) 133 (37.0)  
 3 268 (56.4) 62 (63.3) 206 (57.4)  
 4 26 (5.5) 12 (12.2) 14 (3.9)  
CCI ≥ 5, n (%) 377 (79.4) 87 (82.9) 290 (78.4) 0.342a 
Operative procedure, n (%)    <0.001b 
 LAR/TME 123 (25.9) 10 (9.5) 113 (30.5)  
 APR 43 (9.1) 2 (1.9) 41 (11.1)  
 Left hemicolectomy 146 (30.8) 52 (49.6) 94 (25.4)  
 Transversectomy 8 (1.7) 2 (1.9) 6 (1.6)  
 Right hemicolectomy 114 (24.0) 28 (26.7) 86 (23.2)  
 Subtotal/colectomy 33 (6.9) 9 (8.6) 24 (6.5)  
 Other 8 (1.7) 2 (1.9) 6 (1.6)  
Operative technique, n (%)    0.031b 
 Successful laparoscopic 51 (10.7) 5 (4.8) 46 (12.4)  
 Open 424 (89.3) 100 (95.2) 324 (87.6)  
Operative strategy, n (%)    0.003b 
 Prim. anastomosis 247 (52.0) 43 (41.0) 204 (55.1)  
 Prim. anastomosis, protective 
stoma 
123 (25.9) 26 (24.8) 97 (26.2)  
 No prim. anastomosis, 
definitive stoma 
105 (22.1) 36 (34.4) 69 (18.6)  
Operation time, min, median 
(IQR) 
275 (210-355) 265 (197-320) 280 (214-360) 0.042a 
IQR: interquartile range; BMI: body mass index; ASA score: American Society of Anaesthesiologists score; CCI: 
Charlson comorbidity index; LAR/TME: low anterior resection/total mesorectal excision; APR: abdominoperineal 
resection a Mann Whitney U test; b Fisher’s exact test  
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Table 2: Tumor characteristics 





Localization distal to 
proximal, n (%) 
   <0.001a 
 Rectum 141 (29.7) 10 (9.5) 131 (35.4)  
 Sigmoid 152 (32.0) 50 (47.6) 102 (27.6)  
 Splenic flexure, 
descending c. 
30 (6.3) 15 (14.3) 15 (4.1)  
 Transverse c. 17 (3.6) 5 (4.8) 12 (3.2)  
 Hepatic flexure, 
ascending c. 
59 (12.4) 12 (11.4) 47 (12.7)  
 Cecum 41 (8.6) 11 (10.5) 30 (8.1)  
 Other 35 (7.4) 2 (1.9) 33 (8.9)  
Tumor stage (UICC), n 
(%) 
   <0.001a 
 0 15 (3.2) 2 (1.9) 13 (3.5)  
 I 79 (16.6) 6 (5.7) 73 (19.7)  
 IIA 92 (19.4) 23 (21.9) 69 (18.6)  
 IIB 26 (5.5) 14 (13.3) 12 (3.2)  
 IIIA 12 (2.5) 1 (1.0) 11 (3.0)  
 IIIB 54 (11.4) 12 (11.4) 42 (11.4)  
 IIIC 32 (6.7) 6 (5.7) 26 (7.0)  
 IV 165 (34.7) 41 (39.0) 124 (33.5)  
Total lymph node 
yield, median (IQR) 
21 (15-29) 26 (18-33) 20 (15-27) <0.001b 
 Lymph node yield 
colon, median (IQR) 
23 (16-32) 26 (18-37) 22 (16-30) 0.017b 
 Lymph node yield 
rectum, median (IQR) 
18 (14-25) 25 (17-33) 18 (13-25) 0.069b 
Positive lymph node 
yield, median (IQR) 
3 (1-7) 3 (2-8) 3 (1-7) 0.296b 
Nodal positive (N+), n 
(%) 
219 (46.3) 48 (46.2) 171 (46.3) 1.000a 
Positive resection 
margin (R+), n (%) 




invasion (L+), n (%) 
77 (16.2) 18 (17.1) 59 (16.0) 0.954a 
Vein invasion (V+), n 
(%) 
90 (19.0) 22 (21.0) 68 (18.4) 0.918a 
Neoadjuvant 
chemotherapy, n (%) 
88 (18.5) 3 (2.9) 85 (23.0) <0.001a 
Neoadjuvant 
radiotherapy, n (%) 
71 (14.9) 2 (1.9) 69 (18.6) <0.001a 
IQR: interquartile range; c.: Colon; UICC: Union internationale contre le cancer; a Fisher’s exact test; b 
Mann Whitney U test  
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Table 3: In-hospital and long-term outcomes 






In-hospital outcomes     
Patients with 
complications, n (%) 
249 (52.4) 62 (59.0) 187 (50.5) 0.150a 
 Cardiac event 15 (3.2) 5 (4.8) 10 (2.7) 0.340a 
 Respiratory event 25 (5.3) 7 (6.7) 18 (4.9) 0.461a 
 Aspiration 11 (2.3) 4 (3.8) 7 (1.9) 0.271a 
 Renal insufficiency 18 (3.8) 5 (4.8) 13 (3.5) 0.565a 
 Ileus 28 (5.9) 7 (6.7) 21 (5.7) 0.646a 
 Anastomotic leakage 33 (6.9) 5 (4.8) 28 (7.6) 0.390a 
 Sepsis 18 (3.8) 4 (3.8) 14 (3.8) 1.000a 
 Surgical site infection 141 (29.7) 33 (31.4) 108 (29.2) 0.717a 
  Superficial 91 (19.2) 21 (20.0) 70 (18.9)  
  Deep 11 (2.3) 4 (3.8) 7 (1.9) 0.595a 
  Organ/space 39 (8.2) 8 (7.6) 31 (8.3)  
Hospital length of stay, 
d, median (IQR) 
13 (9-19) 14 (11-23) 13 (9-19) 0.006b 
In-hospital mortality, n 
(%) 
20 (4.2) 9 (8.4) 11 (3.0) 0.023a 
     
Long-term outcomes     
Length of follow-up, d, 
median (IQR) 
445 (67-1,409) 420 (45-1,289) 450 (82-1,450) 0.387b 
Adjuvant 
chemotherapy, n (%) 
137 (28.8) 20 (19.0) 117 (31.6) 0.028a 
Overall survival, n (%) 368 (77.5) 76 (72.4) 292 (78.9) 0.185a 
5-y survival, n (%) 485 (81.1) 79 (75.2) 306 (82.7) 0.091a 
Local recurrence, n 
(%) 
24 (5.1) 7 (6.7) 17 (4.6) 0.448a 
Disease free survival, 
d, median (IQR) 
411 (62-1,374) 383 (43-1,209) 423 (78-1,428) 0.257b 




Table 4: The effect of emergency CRC resection on outcomes 
In-hospital mortality 
 OR 95% CI p value 
unadjusted 2.88 1.23-6.77 0.023 
adjusteda 1.82 0.62-5.40 0.278 
    
Five-year survival 
 HR 95% CI p value 
unadjusted 1.49 0.95-2.35 0.086 
adjustedb 1.38 0.81-2.37 0.237 
    
Five-year local tumor recurrence 
 HR 95% CI p value 
unadjusted 1.59 0.66-3.84 0.299 
adjustedc 1.48 0.47-4.66 0.500 
 
 
OR: odds ratio; HR: Hazard ratio; CI: confidence interval; ASA score: American Society of 
Anaesthesiology score; CCI: Charlson comorbidity index; UICC stage: Union for International Cancer 
Control stage 
a Multivariable logistic regression analysis adjusted for ASA score, tumour localisation, operative strategy, 
neoadjuvant chemo- and radiotherapy 
b Multivariable cox regression analysis adjusted for age, CCI, operative procedure, UICC stage, 
neoadjuvant chemo- and radiotherapy 
c Multivariable cox regression analysis adjusted for age, CCI, operative procedure, UICC stage, 




Fig. 1 Kaplan-Meier curves of a) five-year survival and b) five-year recurrence free survival 




Fig. 2 Kaplan-Meier curves of five-year survival stratified by UICC stages I-IV 
 
